United Kingdom: Food, Drugs, Healthcare, Life Sciences

Geraint Lloyd-Taylor and Brinsley Dresden explore the accelerated implementation of the DMCCA subscription regime, examining recent advertising rulings for less healthy foods and the evolving landscape of environmental marketing claims. The discussion provides actionable guidance for businesses navigating these regulatory changes.

This September edition examines pivotal developments in life sciences patent law across Europe, with the Unified Patent Court continuing to refine its jurisprudence on added matter, intermediary liability, and procedural standards. National courts in the UK, France, and the Netherlands deliver significant rulings on supplementary protection certificates, pro-drugs, and the boundaries of pharmacy exemptions that will shape patent strategy for pharmaceutical and medical device companies.

Nomio, a broccoli-based sports supplement gaining popularity among endurance athletes, has secured patent protection for its innovative use of sulforaphane to enhance exercise performance and treat metabolic conditions. This analysis explores how the company leveraged university research to protect both therapeutic and non-therapeutic applications of their simple three-ingredient formula, demonstrating that even products with common ingredients can achieve robust patent protection through novel use claims.

The National Institute for Health and Care Research has unveiled a groundbreaking £45 million funding initiative through Strategic Infrastructure Partnerships, designed to revolutionize healthcare delivery in England. This multi-year research funding vehicle aims to forge powerful collaborations between NIHR infrastructure and the wider health sector, focusing on community-based care models and independent living technologies. Applications are now open for partnerships addressing urgent care demand red

This September edition examines pivotal developments in life sciences patent law across Europe, with the Unified Patent Court continuing to refine its jurisprudence on added matter, intermediary liability, and procedural standards. National courts in the UK, France, and the Netherlands deliver significant rulings on supplementary protection certificates, pro-drugs, and the boundaries of pharmacy exemptions that will shape patent strategy for pharmaceutical and medical device companies.

As humanity ventures beyond Earth, the challenge of sustaining life in space demands revolutionary approaches to food production. From radiation-resistant seed coatings to microgravity-adapted root systems, innovations in space agriculture are creating new frontiers for patent protection while simultaneously offering solutions to terrestrial farming challenges.

Martha's Rule is a national NHS patient safety initiative that provides patients, families, carers and medical staff with a formal route to request urgent clinical reviews when concerns about deteriorating conditions are not being adequately addressed. This comprehensive guide examines how the Rule operates across England's acute hospital settings, its implementation timeline, and its potential relevance to medical negligence claims.

The World Tetrahand Congress 2026 brings together leading experts and practitioners to explore cutting-edge approaches in tetrahand treatment and rehabilitation. This gathering focuses on innovative strategies to enhance functional outcomes and promote greater independence for patients living with tetraplegia. Attendees will gain valuable insights into the latest research, clinical practices, and technological advances shaping the future of upper limb restoration.

The National Institute for Health and Care Research has unveiled a groundbreaking £45 million funding initiative through Strategic Infrastructure Partnerships, designed to revolutionize healthcare delivery in England. This multi-year research funding vehicle aims to forge powerful collaborations between NIHR infrastructure and the wider health sector, focusing on community-based care models and independent living technologies. Applications are now open for partnerships addressing urgent care demand red